Compare

NanoRepro AG/€NN6

1D1W1M3M6MYTD1Y5YMAX

About NanoRepro AG

NanoRepro AG is a German company operating in the healthcare industry, specializing in the development and distribution of diagnostic rapid tests. The company offers a range of products primarily focused on fertility, infectious diseases, and preventive care, providing over-the-counter solutions that cater to both professional and consumer markets. Founded in 2002, NanoRepro is headquartered in Marburg, Germany. The company leverages a network of distribution partners to enhance its market presence across various countries, reflecting a strategic focus on expanding its geographical footprint. NanoRepro's competitive strength lies in its emphasis on research and development, supporting its capability to introduce innovative diagnostic solutions.
Ticker
€NN6
Sector
Health
Primary listing
XETRA
Employees
22
Headquarters
Marburg, Germany
Website
www.nanorepro.com

NanoRepro AG Metrics

BasicAdvanced
€19M
-
-
-
-

What the Analysts think about NanoRepro AG

Analyst ratings (Buy, Hold, Sell) for NanoRepro AG stock.
Analyst projections of the future price of NanoRepro AG stock.

NanoRepro AG Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

NanoRepro AG Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.